Lewes, DE -- (SBWIRE) -- 07/26/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: Boston Scientific Corporation (NYSE:BSX), Abbott Laboratories (NYSE:ABT), Medtronic, Inc. (NYSE:MDT), Varian Medical Systems, Inc.(NYSE:VAR)
Boston Scientific Corporation (NYSE:BSX) stock moved up +12.70% and finished the day at $10.83. The day started out with a higher opening price of $10.48, versus its prior close of $9.61.The company traded with the total volume of 65.44 million shares, while its average trading volume remained 15.85 million shares. During the last 5 trades the stock jumped almost +12.7%. During the last one month it rose with the percentage of +19.93. Its year to date performance remained progressive +89.01%.
Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties.
Why Should Investors Buy BSX After The Recent Gain? Just Go Here and Find Out
Abbott Laboratories (NYSE:ABT) percentage change mounted +0.36% to close at $36.58 with the total traded volume of 7.49 million shares, and average volume of 7.48 million. The Company’s year to date performance remained optimistic with the rise of +11.69%. If we look at the last 6 months of trade, that is in the bullish zone with an increase of +11.56%. During last trade its minimum price was $36.24 and it gained its highest price of $36.60.
Abbott Laboratories (Abbott), is engaged in the discovery, development, manufacture, and sale of a portfolio of science-based health care products.
Will ABT Continue To Move Higher? Find Out Here
Medtronic, Inc. (NYSE:MDT)started its trading session with the price of $55.18 and closed at $55.38 by scoring +0.53%. MDT’s stocks traded with total volume of 4.18 million shares, while the average trading volume remained 5.03 million shares. Previous 5 days graph demonstrated a positive move of +3.63%. A MDT’s quarterly performance remained in the green with the percentage of +17.75, while its year to date performance showed that the stock advanced overall +35.01%.The 52-week price range of the stock remained $37.26 - $55.63.
Medtronic, Inc. (Medtronic) is engaged in medical technology - alleviating pain, restoring health, and extending life for millions of people worldwide.
For How Long MDT’s Gloss will Attract Investors? Find out via this report
Varian Medical Systems, Inc.(NYSE:VAR), during the previous trading session, the stock showed a positive movement of +2.76%.Year to date performance of the stock remained positive with the rise of +5.5%. VAR traded with volume of 2.92 million shares, while its average trading volume remained 797,887.00 shares. Stock’s closing price was $74.10 while it started its day-trade at $71.60. Its 52-week price range was $52.90 - $75.78.
Varian Medical Systems, Inc. is engaged in the design, manufacture, sale and service of equipment and software products for treating cancer with radiotherapy.
For How Long VAR will Fight for Profitability? Read This Trend Analysis report
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/